Skip to content
Research Article Open access CC BY 4.0

Evaluation of First-Line Coagulation Tests in Highly Active Antiretroviral Therapy (HAART) Naïve and Treated Group of HIV Infected Subjects

Ngwu Amauche Martina, Ozoemena Chiadikobi Lawrence, Umeh Okechukwu Elijah, Ugwu Ifeanyichukwu Basil, Ozoume Chibuike Innocent

Journal of Advances in Medical and Pharmaceutical Sciences · pp. 1–8 · Published 25 Jan 2024

10.9734/jamps/2024/v26i3672

Abstract

Background: Coagulation disorders are common in patients with Human Immunodeficiency virus (HIV). Coagulation abnormalities occur as a result of HIV-related thrombocytopenia, induced hepatotoxicity due to highly active antiretroviral therapy (HAART) that impairs liver function and diminishes the function and synthesis of coagulation factors. The aim of this study was to evaluate prothrombin time (PT), activated partial thromboplastin time (APTT), platelet count, mean platelet volume, plateletcrit and platelet distribution width in HAART-naïve HIV infected patients, HAART treated and HIV-seronegative controls. Place and Duration of Study: Department of Haematology and antiretroviraltherapies (ART) clinic both of Enugu State University of Science and Technology Teaching Hospital, between March and June 2023. Methodology: A total of 150 study participants, consisting of 50 HAART-naïve HIV-infected subjects, 50 HIV-infected subjects who were taking HAART, and 50 HIV-seronegative apparently healthy subjects, were included. Coagulation tests such as PT, APTT were determined by manual procedures. Platelet counts (PC), mean platelet volume (MPV), plateletcrit (PCT), platelet distribution width (PDW) were analyzed by Mindray/BC-5150 automated analyzer. The data were analyzed using SPSS version 21. Analysis of variance (ANOVA) and Pearson correlation analysis were used. P-Value < 0.05 was considered as statistically significant. Results: Mild thrombocytopenia (100-<150 x 109/L) was found in 48% of HIV-infected subjects who were taking HAART, 76% mild thrombocytopenia and 24% moderate thrombocytopenia (50-<100 x109/L) was found in HAART-naïve HIV-infected subjects, but no thrombocytopenia was found in apparently healthy HIV-seronegative control. Prothrombin time and APTT were significantly higher, whereas PC and PDW was significantly lower in HIV-infected subjects (both who were taking HAART and HAART-naïve) than HIV-seronegative subjects (p<0.05). Prothrombin time and APTT were significantly higher, and PC was significantly lower in HAART-naïve HIV-infected subjects than HIV-infected subjects who were taking HAART. In Pearson correlation analysis, PT and APTT has shown a significant negative correlation with a PC in those taking HAART and HAART-naïve HIV-infected subjects, whereas significant positive correlation was found in HIV-seronegative subjects. Conclusion: Prothrombin time and APTT significantly increased, whereas platelet count and PDW significantly decreased in HIV-infected subjects who were taking HAART and HAART-naïve. Basic coagulation parameters need to be monitored regularly in HIV-infected subjects in Enugu.

Prothrombin time activated partial thromboplastin time platelet HIV infected patients HAART

References (23)

  1. 1 District Laboratory Practice in Tropical Countries [DOI]
  2. 2 Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection [DOI]
  3. 3 HIV epidemiology in Nigeria [DOI]
  4. 4 Endothelial Function in HIV-Infected Persons [DOI]
  5. 5 Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients [DOI]
  6. 6 Haematological aspects of HIV infection [DOI]
  7. 7 Haematological changes in HIV infection with correlation to CD4 cell count [DOI]
  8. 8 The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals [DOI]
  9. 9 Assessment of haematological parameters in HIV-infected and uninfected Rwandan women: a cross-sectional study [DOI]
  10. 10 Platelets and HIV-1 Infection: Old and New Aspects [DOI]
  11. 11 Endothelial dysfunction in HIV infection--the role of circulating endothelial cells, microparticles, endothelial progenitor cells and macrophages.
  12. 12 Plasma Levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-Positive Patients Versus 51 HIV-Negative Healthy Controls [DOI]
  13. 13 Prevalence and associated factors of thrombocytopenia among HAART naive HIV positive patients at Gondar university hospital, northwest Ethiopia [DOI]
  14. 14 Hematologic Abnormalities in AIDS [DOI]
  15. 15 Effect of a liquid nutritional supplement on viral load and haematological parameters in HIV-positive/AIDS patients [DOI]
  16. 16 The Correlation of Values of Cd4 Count, Platelet, Pt, Aptt, Fibrinogen and Factor VIII Concentrations among HIV Positive Patients in FMC Owerri [DOI]
  17. 17 Changes in the Incidence of Severe Thrombocytopenia and Its Predisposing Conditions in HIV-Infected Patients Since the Introduction of Highly Active Antiretroviral Therapy [DOI]
  18. 18 Coagulation Parameters in Human Immunodeficiency Virus Infected Patients: A Systematic Review and Meta-Analysis [DOI]
  19. 19 Persistently Elevated Levels of von Willebrand Factor Antigen in HIV Infection [DOI]
  20. 20 von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: independent prognostic relevance of tissue-type plasminogen activator.
  21. 21 Activated Partial Thromboplastin Time, Prothrombin Time, Thrombin Time and Platelet Count Study in HIV Seropositive Subjects at Nnamdi Azikiwe Teaching Hospital Nnewi [DOI]
  22. 22 Extrinsic and intrinsic coagulation pathway, fibrinogen serum level and platelet count in HIV positive patients.
  23. 23 [Changes in blood coagulation in HIV infection].

Cited by 1

Innovative Pharmacological Approaches in Targeting Drug Resistance Mechanisms: A Biomedicine Perspective

Dewi Pangestuti, Nanda Novziransyah · South Eastern European Journal of Public Health · 2025

Article metrics

Real usage data collected on this platform.

47

Page views

0

PDF downloads

31

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.